Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo

Antimicrob Agents Chemother. 2018 Feb 23;62(3):e02091-17. doi: 10.1128/AAC.02091-17. Print 2018 Mar.

Abstract

Although KPC enzymes are most common among carbapenemases produced by Enterobacter cloacae complex globally, the epidemiology varies from one country to another. While previous studies have suggested that IMP enzymes are most common in Japan, detailed analysis has been scarce thus far. Here, we carried out a molecular epidemiological study and plasmid analysis of IMP-1-producing E. cloacae complex isolates collected from three hospitals in central Tokyo using whole-genome sequencing. Seventy-one isolates were classified into several sequence types (STs), and 49 isolates were identified as Enterobacter hormaechei ST78. Isolates of ST78 were divided into three clades by core-genome single nucleotide polymorphism (SNP)-based phylogenetic analysis. Whereas isolates of clade 3 were isolated from only one hospital, isolates of clade 1 and 2 were identified from multiple hospitals. Ten of 12 clade 1 isolates and 1 of 4 clade 2 isolates carried blaIMP-1 on IncHI2 plasmids, with high similarity of genetic structures. In addition, these plasmids shared backbone structures with IncHI2 plasmids carrying blaIMP reported from other countries of the Asia-Pacific region. All isolates of clade 3 except one carried blaIMP-1 in In1426 on IncW plasmids. An isolate of clade 3, which lacked IncW plasmids, carried blaIMP-1 in In1426 on an IncFIB plasmid. These observations suggest that IMP-producing E. cloacae complex isolates with a diversity of host genomic backgrounds have spread in central Tokyo, and they indicate the possible contribution of IncHI2 plasmids toward this phenomenon.

Keywords: Enterobacter cloacae complex; IMP-1; carbapenemase-producing Enterobacteriaceae; metallo-β-lactamase; plasmid; whole-genome sequencing.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology
  • Enterobacter / classification
  • Enterobacter / drug effects
  • Enterobacter / genetics*
  • Enterobacter / isolation & purification
  • Enterobacter cloacae / classification
  • Enterobacter cloacae / drug effects
  • Enterobacter cloacae / genetics*
  • Enterobacter cloacae / isolation & purification
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology
  • Gene Expression
  • Hospitals
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Epidemiology
  • Phylogeny
  • Plasmids / chemistry*
  • Plasmids / metabolism
  • Tokyo / epidemiology
  • Whole Genome Sequencing
  • beta-Lactam Resistance / genetics*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-lactamase IMP-1
  • beta-Lactamases